Skip to main
CI

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 53%
Hold 13%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is a leading provider of pharmacy benefit management and health insurance services with a positive outlook due to strong performance in its PBM and specialty pharmacy services, strategic partnerships with top insurers and employers, and a focus on expanding its Evernorth capabilities. The company's decision to exit the individual ACA exchange business and its commitment to diversity in leadership are also positive factors. However, risks include potential economic impact from this exit, a strategic review of its prior authorization unit, and declines in PBM earnings and scripts.

Bears say

Cigna Group is facing multiple risks, such as high healthcare costs and margin erosion in its PBMs, slow biosimilar adoption, and potential client losses. Despite being undervalued and having a strong diversified business, its potential challenges may hinder its growth. The company's response to the COVID-19 pandemic and initiatives to support customers and communities may help mitigate some risks, but overall its outlook is negative due to potential headwinds in the healthcare industry and risks to its key drivers of growth.

Cigna (CI) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 53% recommend Buy, 13% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 15 analysts, Cigna (CI) has a Buy consensus rating as of May 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $342.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $342.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.